Kyriaki Mitta, Ioannis Tsakiridis, Akriola Fachiridou, Fotios Zachomitros, Themistoklis Dagklis, Apostolos Mamopoulos, Apostolos Athanasiadis, Ioannis Kalogiannidis
Introduction: Borderline ovarian tumors (BOTs) are tumors of low malignant potential commonly presented in women of reproductive age. Their incidence has been increasing over the years and issues regarding fertility preservation are very crucial …
Maria Fanaki, Paraskevas Perros, Vasilios Pergialiotis, Konstantinos Mpramis, Nikolaos Thomakos
Ovarian cancer is the second most common cause of gynecologic cancer death. The most common histologic category of epithelial ovarian cancer is High Grade Serous Ovarian Cancer (HGSOC). The initial management usually involves appropriate staging and debulking surgery. Otherwise, patients with unresectable disease receive neoadjuvant chemotherapy, and then undergo Interval Debulking Surgery (IDS) …
Kehinde S. Okunade, Adaiah Soibi-Harry, Tonia Onyeka, John B. Ogunyemi, Olufemi Thomas-Ogodo, Adebola A. Adejimi, Austin C. Okoro, Benedetto Osunwusi, Sunusi R. Garba, Rose I. Anorlu
Background: The timing of recurrence of epithelial ovarian cancer (EOC) after a standard primary treatment is an important indicator of the degree of response of the tumour to treatment. It, however, remains unclear if the timing of recurrence will predict survival …